John N. Wood

John N. Wood

Auto-generated profile, based on publicly available information

John N. Wood

Molecular Nociception Group, Wolfson Institute for Biomedical Research, UCL, London, UK

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MNMohammed A. Nassar
Mohammed A. Nassar
LSL. Caroline Stirling
L. Caroline Stirling
GFGreta Forlani
Greta Forlani
MBMark D. Baker
Mark D. Baker
EMElizabeth A. Matthews
Elizabeth A. Matthews
JWJohn N. Wood
John N. Wood
Nine voltage-gated sodium channels are expressed in complex patterns in mammalian nerve and muscle. Three channels, Nav1.7, Nav1.8, and Nav1.9, are expressed selectively in peripheral damage-sensing neurons. Because there are no selective blockers of these channels, we used gene ablation in mice to examine the function of Nav1.7 (PN1) in pain pathways. A global Nav1.7-null mutant was found to die shortly after birth. We therefore used the Cre-loxP system to generate nociceptor-specific knockouts. Nav1.8 is only expressed in peripheral, mainly nociceptive, sensory neurons. We knocked Cre recombinase into the Nav1.8 locus to generate heterozygous mice expressing Cre recombinase in Nav1.8-positive sensory neurons. Crossing these animals with mice where Nav1.7 exons 14 and 15 were flanked by loxP sites produced nociceptor-specific knockout mice that were viable and apparently normal. These animals showed increased mechanical and thermal pain thresholds. Remarkably, all inflammatory pain responses evoked by a range of stimuli, such as formalin, carrageenan, complete Freund's adjuvant, or nerve growth factor, were reduced or abolished. A congenital pain syndrome in humans recently has been mapped to the Nav1.7 gene,SCN9A. Dominant Nav1.7 mutations lead to edema, redness, warmth, and bilateral pain in human erythermalgia patients, confirming an important role for Nav1.7 in inflammatory pain. Nociceptor-specific gene ablation should prove useful in understanding the role of other broadly expressed genes in pain pathways.

18 August 1998 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CCChih-Cheng Chen
Chih-Cheng Chen
SESteven England
Steven England
AAArmen N. Akopian
Armen N. Akopian
JWJohn N. Wood
John N. Wood
Proton-gated channels expressed by sensory neurons are of particular interest because low pH causes pain. Two proton-gated channels, acid-sensing ionic channel (ASIC) and dorsal root ASIC (DRASIC), that are members of the amiloride-sensitive ENaC/Degenerin family are known to be expressed by sensory neurons. Here, we describe the cloning and characterization of an ASIC splice variant, ASIC-β, which contains a unique N-terminal 172 aa, as well as unique 5′ and 3′ untranslated sequences. ASIC-β, unlike ASIC and DRASIC, is found only in a subset of small and large diameter sensory neurons and is absent from sympathetic neurons or the central nervous system. The patterns of expression of ASIC and ASIC-β transcripts in rat dorsal root ganglion neurons are distinct. When expressed in COS-7 cells, ASIC-β forms a functional channel with electrophysiological properties distinct from ASIC and DRASIC. The pH dependency and sensitivity to amiloride of ASIC-β is similar to that described for ASIC, but unlike ASIC, the channel is not permeable to calcium, nor are ASIC-β-mediated currents inhibited by extracellular calcium. The unique distribution of ASIC-β suggests that it may play a specialized role in sensory neuron function.

1 June 2010 in Neuron
Verified
Journal Article
Open access
BKBarbara Kremeyer
Barbara Kremeyer
FLFrancisco Lopera
Francisco Lopera
JCJames J. Cox
James J. Cox
AMAliakmal Momin
Aliakmal Momin
FRFrancois Rugiero
Francois Rugiero
ARAndrés Ruiz-Linares
Andrés Ruiz-Linares
Human monogenic pain syndromes have provided important insights into the molecular mechanisms that underlie normal and pathological pain states. We describe an autosomal-dominant familial episodic pain syndrome characterized by episodes of debilitating upper body pain, triggered by fasting and physical stress. Linkage and haplotype analysis mapped this phenotype to a 25 cM region on chromosome 8q12-8q13. Candidate gene sequencing identified a point mutation (N855S) in the S4 transmembrane segment of TRPA1, a key sensor for environmental irritants. The mutant channel showed a normal pharmacological profile but altered biophysical properties, with a 5-fold increase in inward current on activation at normal resting potentials. Quantitative sensory testing demonstrated normal baseline sensory thresholds but an enhanced secondary hyperalgesia to punctate stimuli on treatment with mustard oil. TRPA1 antagonists inhibit the mutant channel, promising a useful therapy for this disorder. Our findings provide evidence that variation in the TRPA1 gene can alter pain perception in humans.

29 August 2012 in Brain
Verified
Journal Article
Open access
PDF file
NENiels N. Eijkelkamp
Niels N. Eijkelkamp
JLJohn E. Linley
John E. Linley
MBMark D. Baker
Mark D. Baker
MMMichael S. Minett
Michael S. Minett
RCRoman Cregg
Roman Cregg
JWJohn N. Wood
John N. Wood
The activity of voltage-gated sodium channels has long been linked to disorders of neuronal excitability such as epilepsy and chronic pain. Recent genetic studies have now expanded the role of sodium channels in health and disease, to include autism, migraine, multiple sclerosis, cancer as well as muscle and immune system disorders. Transgenic mouse models have proved useful in understanding the physiological role of individual sodium channels, and there has been significant progress in the development of subtype selective inhibitors of sodium channels. This review will outline the functions and roles of specific sodium channels in electrical signalling and disease, focusing on neurological aspects. We also discuss recent advances in the development of selective sodium channel inhibitors.

7 September 2004 in Journal of Neurobiology
Verified
Journal Article
Closed access
PDF file
JWJohn N. Wood
John N. Wood
JBJames P. Boorman
James P. Boorman
KOKenji Okuse
Kenji Okuse
MBMark D. Baker
Mark D. Baker

1 January 2012 in Nature Communications
Verified
Journal Article
Open access
PDF file
MMMichael S. Minett
Michael S. Minett
MNMohammed A. Nassar
Mohammed A. Nassar
ACAnna K. Clark
Anna K. Clark
GPGayle Passmore
Gayle Passmore
ADAnthony H. Dickenson
Anthony H. Dickenson
JWJohn N. Wood
John N. Wood
Human acute and inflammatory pain requires the expression of voltage-gated sodium channel Nav1.7 but its significance for neuropathic pain is unknown. Here we show that Nav1.7 expression in different sets of mouse sensory and sympathetic neurons underlies distinct types of pain sensation. Ablating Nav1.7 gene (SCN9A) expression in all sensory neurons using Advillin-Cre abolishes mechanical pain, inflammatory pain and reflex withdrawal responses to heat. In contrast, heat-evoked pain is retained when SCN9A is deleted only in Nav1.8-positive nociceptors. Surprisingly, responses to the hotplate test, as well as neuropathic pain, are unaffected when SCN9A is deleted in all sensory neurons. However, deleting SCN9A in both sensory and sympathetic neurons abolishes these pain sensations and recapitulates the pain-free phenotype seen in humans with SCN9A loss-of-function mutations. These observations demonstrate an important role for Nav1.7 in sympathetic neurons in neuropathic pain, and provide possible insights into the mechanisms that underlie gain-of-function Nav1.7-dependent pain conditions.